Use of sofosbuvir based regimen in patients with end-stage renal disease and chronic hepatitis C; an open label, non-randomized, single arm, single center study from Pakistan

AIM: we aimed to determine the virological response and safety of Sofosbuvir-based direct-acting antiviral agents (DAAs) in chronic hepatitis C (CHC) patients on long-term hemodialysis (HD). BACKGROUND: With the advent of interferon-free DAAs, the treatment of CHC has been revolutionized. Pakistan i...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Gastroenterol Hepatol Bed Bench
Hoofdauteurs: Mandhwani, Rajesh, Hanif, Farina M., Lail, Ghulamullah, Luck, Nasir Hassan, Khalid, Muhammad Ali, ul Haque, Muhammad Manzoor, Laeeq, Syed Mudassir, Aziz, Tahir
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Shaheed Beheshti University of Medical Sciences 2020
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7149816/
https://ncbi.nlm.nih.gov/pubmed/32308935
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items